Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, Girona J, Martínez-Montoro JI, Ortega E, Pérez-Pérez A, Sánchez-Margalet V, Pedro-Botet J, Ribalta J; Cardiovascular Disease Group of the Spanish Society of Diabetes. Guardiola M, et al. Among authors: botana m. Eur J Clin Invest. 2024 Apr 13:e14214. doi: 10.1111/eci.14214. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38613414 Review.
Cyclophilin B serum levels present variations across the menstrual cycle.
Alvariño R, Gil-Mouce C, Botana MA, Gegunde S, González-Jartín J, Vieytes MR, Alfonso A, Botana LM. Alvariño R, et al. Among authors: botana ma. Sci Rep. 2023 Jun 22;13(1):10139. doi: 10.1038/s41598-023-37322-7. Sci Rep. 2023. PMID: 37349369 Free PMC article.
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk.
Cebrian A, Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Manito N, Botana M, Alcázar R. Cebrian A, et al. Among authors: botana m. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):292-294. doi: 10.1016/j.nefroe.2021.11.016. Epub 2022 Dec 7. Nefrologia (Engl Ed). 2024. PMID: 36494287 Free article. No abstract available.
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.
Sundström J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, Taveira-Gomes T, Botana M, Birkeland KI, Thuresson M, Jäger L, Sood MM, VanPottelbergh G, Tangri N; CaReMe CKD Investigators. Sundström J, et al. Among authors: botana m. Lancet Reg Health Eur. 2022 Jun 30;20:100438. doi: 10.1016/j.lanepe.2022.100438. eCollection 2022 Sep. Lancet Reg Health Eur. 2022. PMID: 36090671 Free PMC article.
Risk of outcomes in a Spanish population with chronic kidney disease.
Alcázar R, Escobar C, Palacios B, Aranda U, Varela L, Capel M, Sicras A, Sicras A, Hormigo A, Manito N, Botana M. Alcázar R, et al. Among authors: botana m. Clin Kidney J. 2022 Mar 5;15(7):1415-1424. doi: 10.1093/ckj/sfac066. eCollection 2022 Jul. Clin Kidney J. 2022. PMID: 35756747 Free PMC article.
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease.
Cebrian A, Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Manito N, Botana M, Alcázar R. Cebrian A, et al. Among authors: botana m. Clin Kidney J. 2022 Feb 10;15(6):1204-1208. doi: 10.1093/ckj/sfac019. eCollection 2022 Jun. Clin Kidney J. 2022. PMID: 35664262 Free PMC article. No abstract available.
59 results